CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Creating A Sustainable Business Model For Cell And Gene Therapies

  Avoid product launch delays and expand patient access to CGTs by understanding and meeting regulatory guidelines and securing approval for reimbursement of treatment costs.

• Characterization Of The Colon Intestine-Chip

  Learn about the development and characterization of Organ-Chips and what makes them the most comprehensive model of the colonic epithelial-endothelial interface that is commercially available.

• Optimizing Human iPSC Aggregate And Organoid Production For Bioprinting

  This study aimed to identify the optimal cell culture conditions to yield high cell density and maintain high cell viability with consistent aggregate morphology and pluripotency marker expression.

• Natural Killer Cell Expansion And Scale-Up In Vertical-Wheel Bioreactors

  Allogeneic Natural Killer (NK) cell therapy offers a promising avenue for cancer immunotherapy. However, traditional platforms struggle to achieve the scalability required for clinical translation and commercial manufacturing.

• Flow Cytometry Analysis Of Chemokine Receptors Expressed On Human NK Cells

  Learn how the knowledge generated by a deep and thorough analysis of chemokine receptors on natural killer (NK) cells can be helpful to scientists studying certain cancers and diseases.

• Understanding Biosafety Levels

  Compliance with biosafety levels (BSLs) is crucial in ensuring that your laboratories meet stringent standards to protect staff and prevent the escape of biological agents.

• Global Outlook Of Multi-Specific Monoclonal Antibodies: Asia Pacific Focus

  Learn about the global clinical trial landscape of multi-specific monoclonal antibodies (Mabs), with emphasis on trends in the Asia Pacific, and recent advancements in the field.

• Process Validation Considerations

  Process validation is a crucial step for successful registration and commercial manufacturing. Learn how to determine the right timing and properly apply a risk-based approach.

• Navigating The Global Epilepsy Clinical Trial Terrain In 2024

  Explore the forefront of epilepsy research with Novotech CRO's comprehensive analysis, unveiling innovative therapies, clinical trials, and future trends shaping epilepsy care.

• Overcoming Challenges In AAV And LV Viral Vector Manufacturing

  Manufacturing viral vectors leaves sponsors vulnerable to high costs, delays, and the possibility of failure. The right CDMO partner can help you reduce timelines and costs for viral vector production.